企業プロフィール
Inozyme 株価・ニュース・カタリスト
- ティッカー:
- INZY
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for INZY.
企業概要
事業概要
Inozyme Pharma is a rare-disease company focused on tissue calcification and enzyme replacement biology. Its story centers on highly specialized pediatric and orphan indications.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Inozyme sits in specialty biotechnology.
ビジネスモデルの特徴
The business depends on clinical data, orphan-disease progress, and the ability to build value in a narrow rare-disease market.
バイオ業界での位置付け
Inozyme is a rare-disease catalyst name whose stock reacts to proof-of-concept and regulatory steps.
今後のカタリスト
- Inozyme’s catalyst is INZ-701 in ENPP1 deficiency, plus any next-stage update that supports the mineralization-disease thesis. This remains a focused rare-disease story.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。